2021
DOI: 10.1016/j.visj.2020.100920
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 patient with symptomatic bradycardia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
15
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 1 publication
(1 reference statement)
0
15
0
Order By: Relevance
“…Given the patient’s presentation, special attention was given to both intrinsic and extrinsic cardiac causes of sinus node dysfunction [ 7 ], Initial chemistry was unremarkable and electrolytes were repleted daily throughout the hospital course. All nodal blocking pharmacologic agents were held in the setting of persistent bradycardia.…”
Section: Discussionmentioning
confidence: 99%
“…Given the patient’s presentation, special attention was given to both intrinsic and extrinsic cardiac causes of sinus node dysfunction [ 7 ], Initial chemistry was unremarkable and electrolytes were repleted daily throughout the hospital course. All nodal blocking pharmacologic agents were held in the setting of persistent bradycardia.…”
Section: Discussionmentioning
confidence: 99%
“…1 An affected patient can be asymptomatic or extra-pulmonary symptoms could be the leading cause of presentation. 2 The disease spreads mostly through respiratory droplets during close contact. Other modes of transmission, such as the ocular route, should not be overlooked as SARS‐CoV‐2 RNA has been detected in tears and conjunctival secretions of patients with COVID‐19.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, affected patients may be asymptomatic or may present due to diseases in other organs like the heart or the eye. [ 1 , 2 ]…”
Section: Discussionmentioning
confidence: 99%